Home / CURA.TO : TSX

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does CURA.TO make money? Does CURA.TO have pricing power? What's the Earnings Whisper? Will CURA.TO profit more as the business scales? What is CURA.TO's management track record? Is CURA.TO's current price justified?

Curaleaf Holdings, Inc.

CAD 13.94 +$3.20 (+29.80%)

TSX · 15 Sep 2026 16:38 UTC

Previous Close

CAD 14.05

Day Range

CAD 13.7CAD 13.98

Year Range

CAD 7.77CAD 20.93

Market Cap

3.24B

AVG Volume

191.94K

Trailing/Forward PE

-72.74/-

PEG ratio

0.05

Dividend Yield

Next Earnings Date

2026-11-04

Primary Exchange

Toronto Stock Exchange

Revenue (USD) · TTM

CURA.TO Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	1.31B
26 Q1	1.29B
25 Q4	1.28B
25 Q3	1.28B
25 Q2	1.29B
25 Q1	1.31B
24 Q4	1.34B
24 Q3	1.37B
24 Q2	1.37B
24 Q1	1.36B

Net Income (USD) · TTM

CURA.TO Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-36.93M
26 Q1	-114.13M
25 Q4	-243.85M
25 Q3	-260.68M
25 Q2	-244.34M
25 Q1	-228.21M
24 Q4	-215.24M
24 Q3	-202.65M
24 Q2	-254.3M
24 Q1	-276.66M

Operating Income (USD) · TTM

CURA.TO Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	11.85M
26 Q1	11.02M
25 Q4	18.1M
25 Q3	5.86M
25 Q2	11.06M
25 Q1	15.32M
24 Q4	20.14M
24 Q3	43.77M
24 Q2	49.76M
24 Q1	37.93M

EBITDA (USD) · TTM

CURA.TO EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	165.43M
26 Q1	189.94M
25 Q4	217.12M
25 Q3	204.29M
25 Q2	220.14M
25 Q1	217.71M
24 Q4	226.38M
24 Q3	265.67M
24 Q2	244.63M
24 Q1	225.15M

Cash Flows (USD) · TTM

CURA.TO Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	76.12M
26 Q1	54.52M
25 Q4	74.34M
25 Q3	66.89M
25 Q2	49.54M
25 Q1	62.65M
24 Q4	64.57M
24 Q3	27.35M
24 Q2	42.49M
24 Q1	34.03M

EPS (USD) · TTM

CURA.TO EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-0.15
26 Q1	-0.44
25 Q4	-0.92
25 Q3	-0.98
25 Q2	-0.92
25 Q1	-0.87
24 Q4	-0.86
24 Q3	-0.82
24 Q2	-1.05
24 Q1	-1.15

Expenses (USD) · TTM

CURA.TO Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	553.02M
26 Q1	533.94M
25 Q4	520.27M
25 Q3	531.77M
25 Q2	535.49M
25 Q1	548.8M
24 Q4	553.2M
24 Q3	531.84M
24 Q2	513.8M
24 Q1	498.22M

Shares Outstanding (USD) · TTM

CURA.TO Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-42.77M
26 Q1	-40.78M
25 Q4	-35.74M
25 Q3	-28.72M
25 Q2	-24.45M
25 Q1	-22.81M
24 Q4	-25.7M
24 Q3	-26.2M
24 Q2	-26.38M
24 Q1	-25.79M

Free Cash Flow Yield

CURA.TO Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	2.08%
Sep 26	2.2%
Sep 26	2.13%
Aug 26	2.18%
Aug 26	2.11%
Aug 26	2.23%
Aug 26	2.27%
Jul 26	2.38%
Jul 26	2.29%
Jul 26	2.25%
Jul 26	2.21%
Jul 26	2.05%
Jun 26	2.9%
Jun 26	2.91%
Jun 26	2.92%
Jun 26	2.48%
May 26	2.74%
May 26	2.88%
May 26	2.82%
May 26	2.48%
May 26	2.85%
Apr 26	2.91%
Apr 26	3.53%
Apr 26	4.14%
Apr 26	3.99%
Mar 26	4.43%
Mar 26	4.03%
Mar 26	3.75%
Mar 26	3.72%
Feb 26	3.78%
Feb 26	3.74%
Feb 26	3.63%
Feb 26	3.69%
Jan 26	4%
Jan 26	3.27%
Jan 26	3.33%
Jan 26	3.51%
Jan 26	3.39%
Dec 25	2.38%
Dec 25	2.18%
Dec 25	1.77%
Dec 25	2.38%
Nov 25	2.82%
Nov 25	3.06%
Nov 25	3.17%
Nov 25	2.47%
Oct 25	2.32%
Oct 25	2.27%
Oct 25	2.28%
Oct 25	2.16%
Oct 25	2.17%
Sep 25	3.55%
Sep 25	3.24%
Sep 25	3.5%
Sep 25	2.92%
Aug 25	2.56%
Aug 25	2.98%
Aug 25	3.16%
Aug 25	4.13%
Aug 25	5.92%
Jul 25	5.88%
Jul 25	8.42%
Jul 25	7.24%
Jul 25	9.77%
Jun 25	10.81%
Jun 25	11.06%
Jun 25	10.83%
Jun 25	9.76%
May 25	10.48%
May 25	10.03%
May 25	10.56%
May 25	10.63%
May 25	9.17%
Apr 25	9.12%
Apr 25	8.98%
Apr 25	10.76%
Apr 25	11.56%
Mar 25	3.69%
Mar 25	4.13%
Mar 25	3.95%
Mar 25	3.57%
Feb 25	2.76%
Feb 25	2.54%
Feb 25	2.52%
Feb 25	2.3%
Jan 25	2.83%
Jan 25	2.84%
Jan 25	2.45%
Jan 25	2.58%
Jan 25	2.3%
Dec 24	2.42%
Dec 24	2.5%
Dec 24	2.34%
Dec 24	2.14%
Nov 24	1.92%
Nov 24	1.89%
Nov 24	1.66%
Nov 24	1.74%
Nov 24	1.95%
Oct 24	1.67%

Price to Sales

CURA.TO Price to Sales by quarter
Period	Price to Sales
Sep 26	2.03
Sep 26	1.92
Sep 26	1.98
Aug 26	1.94
Aug 26	2
Aug 26	1.9
Aug 26	1.86
Jul 26	1.77
Jul 26	1.84
Jul 26	1.88
Jul 26	1.91
Jul 26	2.06
Jun 26	2
Jun 26	1.99
Jun 26	1.98
Jun 26	2.33
May 26	2.12
May 26	2.01
May 26	2.05
May 26	2.34
May 26	2.03
Apr 26	1.99
Apr 26	1.64
Apr 26	1.4
Apr 26	1.45
Mar 26	1.18
Mar 26	1.3
Mar 26	1.4
Mar 26	1.41
Feb 26	1.39
Feb 26	1.4
Feb 26	1.44
Feb 26	1.42
Jan 26	1.31
Jan 26	1.6
Jan 26	1.57
Jan 26	1.49
Jan 26	1.55
Dec 25	1.62
Dec 25	1.77
Dec 25	2.18
Dec 25	1.62
Nov 25	1.37
Nov 25	1.26
Nov 25	1.21
Nov 25	1.56
Oct 25	1.66
Oct 25	1.7
Oct 25	1.69
Oct 25	1.78
Oct 25	1.78
Sep 25	1.34
Sep 25	1.47
Sep 25	1.36
Sep 25	1.63
Aug 25	1.86
Aug 25	1.6
Aug 25	1.51
Aug 25	1.15
Aug 25	0.81
Jul 25	0.81
Jul 25	0.57
Jul 25	0.66
Jul 25	0.49
Jun 25	0.45
Jun 25	0.44
Jun 25	0.44
Jun 25	0.49
May 25	0.46
May 25	0.48
May 25	0.46
May 25	0.45
May 25	0.53
Apr 25	0.53
Apr 25	0.54
Apr 25	0.45
Apr 25	0.42
Mar 25	0.54
Mar 25	0.49
Mar 25	0.51
Mar 25	0.56
Feb 25	0.73
Feb 25	0.79
Feb 25	0.79
Feb 25	0.87
Jan 25	0.71
Jan 25	0.71
Jan 25	0.82
Jan 25	0.78
Jan 25	0.87
Dec 24	0.83
Dec 24	0.8
Dec 24	0.86
Dec 24	0.94
Nov 24	1.05
Nov 24	1.06
Nov 24	1.21
Nov 24	1.15
Nov 24	1.59
Oct 24	1.86

EV/EBITDA

CURA.TO EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	18.71
Sep 26	17.97
Sep 26	18.43
Aug 26	18.09
Aug 26	18.5
Aug 26	17.82
Aug 26	17.57
Jul 26	16.98
Jul 26	17.44
Jul 26	17.68
Jul 26	17.91
Jul 26	18.96
Jun 26	16.13
Jun 26	16.08
Jun 26	16.03
Jun 26	18.08
May 26	16.81
May 26	16.19
May 26	16.43
May 26	18.13
May 26	16.31
Apr 26	16.06
Apr 26	14.01
Apr 26	12.57
Apr 26	12.88
Mar 26	10.97
Mar 26	11.71
Mar 26	12.3
Mar 26	12.38
Feb 26	12.25
Feb 26	12.33
Feb 26	12.59
Feb 26	12.44
Jan 26	11.77
Jan 26	13.59
Jan 26	13.41
Jan 26	12.9
Jan 26	13.24
Dec 25	12.83
Dec 25	13.69
Dec 25	16.11
Dec 25	12.8
Nov 25	11.34
Nov 25	10.71
Nov 25	10.46
Nov 25	12.48
Oct 25	13.07
Oct 25	13.27
Oct 25	13.23
Oct 25	13.76
Oct 25	13.75
Sep 25	11.43
Sep 25	12.22
Sep 25	11.56
Sep 25	13.18
Aug 25	14.56
Aug 25	12.98
Aug 25	12.44
Aug 25	10.29
Aug 25	8.19
Jul 25	8.22
Jul 25	6.75
Jul 25	7.3
Jul 25	6.27
Jun 25	6
Jun 25	5.94
Jun 25	5.99
Jun 25	6.28
May 25	6.08
May 25	6.2
May 25	6.06
May 25	6.05
May 25	6.47
Apr 25	6.49
Apr 25	6.54
Apr 25	6.01
Apr 25	5.83
Mar 25	5.64
Mar 25	5.35
Mar 25	5.46
Mar 25	5.73
Feb 25	6.58
Feb 25	6.9
Feb 25	6.93
Feb 25	7.33
Jan 25	6.49
Jan 25	6.48
Jan 25	7.06
Jan 25	6.85
Jan 25	7.32
Dec 24	7.1
Dec 24	6.98
Dec 24	7.25
Dec 24	7.67
Nov 24	8.22
Nov 24	8.31
Nov 24	9.06
Nov 24	8.76
Nov 24	12.03
Oct 24	13.53

Price/Operating Cashflow

CURA.TO Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	22.03
Sep 26	20.84
Sep 26	21.57
Aug 26	21.04
Aug 26	21.7
Aug 26	20.6
Aug 26	20.21
Jul 26	19.26
Jul 26	20
Jul 26	20.38
Jul 26	20.75
Jul 26	22.43
Jun 26	18.55
Jun 26	18.47
Jun 26	18.39
Jun 26	21.62
May 26	19.61
May 26	18.65
May 26	19.02
May 26	21.69
May 26	18.84
Apr 26	18.44
Apr 26	15.23
Apr 26	12.97
Apr 26	13.46
Mar 26	10.6
Mar 26	11.67
Mar 26	12.52
Mar 26	12.63
Feb 26	12.44
Feb 26	12.56
Feb 26	12.93
Feb 26	12.72
Jan 26	11.75
Jan 26	14.36
Jan 26	14.1
Jan 26	13.38
Jan 26	13.87
Dec 25	15.27
Dec 25	16.66
Dec 25	20.57
Dec 25	15.24
Nov 25	12.88
Nov 25	11.86
Nov 25	11.45
Nov 25	14.71
Oct 25	15.67
Oct 25	15.99
Oct 25	15.93
Oct 25	16.78
Oct 25	16.77
Sep 25	11.09
Sep 25	12.18
Sep 25	11.27
Sep 25	13.49
Aug 25	15.38
Aug 25	13.22
Aug 25	12.48
Aug 25	9.54
Aug 25	6.66
Jul 25	6.7
Jul 25	4.68
Jul 25	5.44
Jul 25	4.03
Jun 25	3.67
Jun 25	3.59
Jun 25	3.67
Jun 25	4.07
May 25	3.79
May 25	3.96
May 25	3.76
May 25	3.74
May 25	4.33
Apr 25	4.35
Apr 25	4.42
Apr 25	3.69
Apr 25	3.44
Mar 25	6.3
Mar 25	5.62
Mar 25	5.88
Mar 25	6.5
Feb 25	8.41
Feb 25	9.14
Feb 25	9.2
Feb 25	10.11
Jan 25	8.2
Jan 25	8.18
Jan 25	9.49
Jan 25	9.01
Jan 25	10.08
Dec 24	9.58
Dec 24	9.3
Dec 24	9.92
Dec 24	10.87
Nov 24	12.11
Nov 24	12.32
Nov 24	14.01
Nov 24	13.33
Nov 24	18.03
Oct 24	21.07

Price to Book

CURA.TO Price to Book by quarter
Period	Price to Book
Sep 26	2.88
Sep 26	2.72
Sep 26	2.82
Aug 26	2.75
Aug 26	2.83
Aug 26	2.69
Aug 26	2.64
Jul 26	2.52
Jul 26	2.61
Jul 26	2.66
Jul 26	2.71
Jul 26	2.93
Jun 26	3.06
Jun 26	3.05
Jun 26	3.04
Jun 26	3.57
May 26	3.24
May 26	3.08
May 26	3.14
May 26	3.58
May 26	3.11
Apr 26	3.04
Apr 26	2.51
Apr 26	2.14
Apr 26	2.22
Mar 26	1.7
Mar 26	1.87
Mar 26	2.01
Mar 26	2.03
Feb 26	2
Feb 26	2.02
Feb 26	2.08
Feb 26	2.04
Jan 26	1.89
Jan 26	2.31
Jan 26	2.27
Jan 26	2.15
Jan 26	2.23
Dec 25	2.23
Dec 25	2.43
Dec 25	3
Dec 25	2.22
Nov 25	1.88
Nov 25	1.73
Nov 25	1.67
Nov 25	2.14
Oct 25	2.28
Oct 25	2.33
Oct 25	2.32
Oct 25	2.45
Oct 25	2.44
Sep 25	1.83
Sep 25	2.01
Sep 25	1.86
Sep 25	2.23
Aug 25	2.54
Aug 25	2.18
Aug 25	2.06
Aug 25	1.57
Aug 25	1.1
Jul 25	1.11
Jul 25	0.77
Jul 25	0.9
Jul 25	0.67
Jun 25	0.6
Jun 25	0.59
Jun 25	0.6
Jun 25	0.67
May 25	0.62
May 25	0.65
May 25	0.62
May 25	0.61
May 25	0.71
Apr 25	0.71
Apr 25	0.72
Apr 25	0.6
Apr 25	0.56
Mar 25	0.68
Mar 25	0.61
Mar 25	0.64
Mar 25	0.71
Feb 25	0.91
Feb 25	0.99
Feb 25	1
Feb 25	1.1
Jan 25	0.89
Jan 25	0.89
Jan 25	1.03
Jan 25	0.98
Jan 25	1.09
Dec 24	1.04
Dec 24	1.01
Dec 24	1.08
Dec 24	1.18
Nov 24	1.32
Nov 24	1.34
Nov 24	1.52
Nov 24	1.45
Nov 24	1.97
Oct 24	2.3

No video analysis for this stock yet. Request one from our team.

News: CURA.TO

gurufocus.com · 15 Sep 2026

Curaleaf Sends Letter to Aurora Shareholders

Curaleaf Sends Letter to Aurora ShareholdersPR NewswireSTAMFORD, Conn., Sept. 15, 2026Encourages Them to Tender Their Shares and Become Owners of the World's Le

gurufocus.com · 14 Sep 2026

Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts

Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The FactsPR NewswireEDMONTON, AB, Sept. 14, 2026NASDAQ | TSX: ACBCuraleaf's anno

gurufocus.com · 2 Sep 2026

Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders

Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders PR Newswire

gurufocus.com · 31 Aug 2026

Curaleaf Expands Florida Reach with Cutler Bay Dispensary Opening

Curaleaf Expands Florida Reach with Cutler Bay Dispensary Opening PR Newswire STAMFORD, Conn., Aug. 31, 2026